Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

Search
Advanced Search
OPEN ACCESS
mobile search button mobile menu button

Articles

Page Path
HOME > Cancer Res Treat > Volume 43(1); 2011 > Article
Special Article Prediction of Cancer Incidence and Mortality in Korea, 2011
Kyu-Won Jung, MS1, Sohee Park, PhD1, Young-Joo Won, PhD1, Hyun-Joo Kong, MS1, Joo Young Lee, MD1, Eun-Cheol Park, MD, PhD2, Jin-Soo Lee, MD, PhD1
Cancer Research and Treatment : Official Journal of Korean Cancer Association 2011;43(1):12-18.
DOI: https://doi.org/10.4143/crt.2011.43.1.12
Published online: March 31, 2011

1The Korea Central Cancer Registry, Division of Cancer Registration and Surveillance, National Cancer Center, Goyang, Korea.

2National Cancer Control Institute, National Cancer Center, Goyang, Korea.

Correspondence: Sohee Park, PhD. The Korea Central Cancer Registry, Division of Cancer Registration and Surveillance, National Cancer Center, Madu 1-dong, Ilsandong-gu, Goyang 410-769, Korea.
Tel: 82-31-920-2015, Fax: 82-31-920-2179, shpark@ncc.re.kr
• Received: February 22, 2011   • Accepted: March 3, 2011

Copyright © 2011 by the Korean Cancer Association

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 12,133 Views
  • 77 Download
  • 38 Crossref
  • 36 Scopus
prev next
Full Article

Download PDF Download PDF

  • Purpose
    To estimate the current cancer burden in Korea, cancer incidence and mortality were projected for the year 2011.
  • Materials and Methods
    The cancer incidence data from 1999-2008 were obtained from the Korea National Cancer Incidence Database, and the cancer mortality data from 1993-2009 were obtained from the Korea National Statistics Office. Cancer incident cases and rates in 2011 were projected from fitting a linear regression model on observed age-specific cancer incidence rates against observed years, then multiplying the projected age-specific rates by the age-specific population. For cancer mortality, a similar procedure was applied for projection except that a Joinpoint regression model was used to determine at which year the linear trend significantly changed.
  • Results
    A total of 216,809 new cancer cases and 71,036 cancer deaths are projected to occur in Korea in 2011. For all sites combined, the crude incidence rates are projected to be 437.9 and 420.5 and the age-standardized incidence rates are projected to be 336.5 and 279.7 per 100,000 for men and women, respectively.
  • Conclusion
    Cancer has become an important public health concern in Korea, and as Korea becomes an aged society, the cancer burden will continue to increase.
  • Key words: Incidence, Mortality, Neoplasms, Prediction, Korea, 2011
Having been the leading cause of death since 1983 [1], cancer has become a major public health concern in Korea. Annually, over 170,000 patients are newly diagnosed with cancer in Korea and one out of four deaths is due to cancer [2,3]. While the cancer registration system in Korea is very efficient and can provide the nationwide cancer statistics within a relatively short time, at least a 2-year lag time behind the current year is still needed because of the time required for data collection and compilation. In order to plan and apply a cancer control program for the current year, it is important to assess the number of new cancer cases and cancer deaths that are expected to occur during the current year. In this report, we provide the projected cancer incidence and mortality on the basis of observed data of up to year 2008.
The Korea Ministry of Health and Welfare initiated a nationwide, hospital-based cancer registry (the Korea Central Cancer Registry [KCCR]) in 1980. The details of the history, objectives, and activities of the KCCR have been documented [4]. Incidence data from 1999-2008 were obtained from the Korea National Cancer Incidence Database (KNCI DB). Cancer cases were classified according to the International Classification of Diseases for Oncology, 3rd edition [5] and converted according to the International Classification of Diseases, 10th edition (ICD-10) [6].
Mortality data from 1993-2009 were obtained from the Korea National Statistics Office (KNSO) [1]. The cause of death was coded and classified according to ICD-10.
The cancer sites included in this report are all cancers combined and 22 common cancers: lip, mouth, and pharynx (C00-C14), esophagus (C15), stomach (C16), colon and rectum (C18-C20), liver and intrahepatic bile duct (liver) (C22), gallbladder and other parts of the biliary tract (gallbladder) (C23-C24), pancreas (C25), lung and bronchus (lung) (C33-C34), breast (C50), uterine cervix (C53), uterine corpus (C54), ovary (C56), prostate (C61), testis (C62), kidney (C64), bladder (C67), brain and central nervous system (C70-C72), thyroid (C73), Hodgkin lymphoma (C81), non-Hodgkin lymphoma (C82-C85, C96), multiple myeloma (C90), leukemia (C91-C95), and all others.
The population data were obtained from the resident registration population at the KNSO. The mid-year population on July 1 of the respective year was applied when computing the incident cases, deaths, and rates.
Because the most recent year for which incidence and mortality data are available is usually 2-3 years behind the current year due to the time required for the data collection and analysis, we projected the expected number of new cancer cases and deaths in Korea of the current year to provide an estimate of the current cancer burden.
Linear regression models [7] were used to assess the time trend and the projection of rates. Based on the observed cancer incidence data, a linear regression model was fitted to the age-specific rates by 5-year age group against years. From the projected age-specific rates in 2011, the number of estimated cancer incident cases was calculated by multiplying the rates by age-specific population size in 2011. For thyroid and prostate cancer that showed significant curve-linear trends, we used a square root transformation when fitting a linear regression model and converted the predicted values back to the original scale.
To estimate the number of cancer deaths in 2011, we first ran a Joinpoint regression model on the data from 1993-2009 to detect the year of significant changes in the trend of cancer mortality separately by sex and cancer site. A Joinpoint regression describes the changes in data trends by connecting several different line segments on a log scale at "joinpoints." This analysis was performed using Joinpoint software (version 3.3, http://srab.cancer.gov/joinpoint) from the Surveillance Research Program of the National Cancer Institute in the US [8]. After identifying the year of significant trend changes from a Joinpoint regression analysis, a simple linear regression model was fitted to the last line segment to estimate age-specific cancer mortality rates in 2011. Similar to the method used for the projection of cancer incidence, the number of new deaths was then projected by multiplying the age-specific cancer mortality rates by respective age-specific population.
We summarized the results using the crude rates (CRs) and age-standardized rates (ASRs) of cancer incidence and mortality. The ASRs were standardized using the World Health Organization (WHO) world standard population [9].
1. Incidence
Table 1 presents the estimated number of new cancer cases and deaths during 2011 in Korea by sex and cancer site. It is projected that 216,809 cancer incident cases will occur during the year 2011.
Table 2 presents the estimated CRs and ASRs of cancer incidence in 2011 by sex and cancer site. The CRs of all sites combined in 2011 are projected to be 437.9 and 420.5 per 100,000 in men and women, respectively, and the ASRs of all sites combined are projected to be 336.5 and 279.7 per 100,000. In males, the five leading primary sites of cancer are expected to be the stomach (CR, 83.3; ASR, 62.9), colon and rectum (CR, 71.4; ASR, 54.2), lung (CR, 61.2; ASR, 47.3), liver (CR, 49.2; ASR, 36.6), and prostate (CR, 37.6; ASR, 29.5), accounting for 69.1% of all newly diagnosed cancers in 2011. In females, the most common cancer sites are expected to be thyroid (CR, 128.4; ASR, 92.5), breast (CR, 60.9; ASR, 42.2), colon and rectum (CR, 46.4; ASR, 28.4), stomach (CR, 39.5; ASR, 24.4), lung (CR, 25.4; ASR, 14.5), and liver (CR, 16.8; ASR, 10.2), accounting for 75.5% of all newly diagnosed cancers (Fig. 1). Thyroid cancer alone is projected to account for 30.5% (32,363 cases) of incident cases in women in 2011.
Table 3 presents the most common cancer sites expected in 2011 by sex and age group. Leukemia and thyroid cancer will be the most common forms of cancer in both sexes 0-14 and 15-34 years of age, respectively. Gastric cancer is predicted to be the most common cancer in males 35-64 years of age, while lung cancer is predicted to be more frequent for males≥65 years of age. The most common sites of cancer will be thyroid for females 35-64 years of age, while colorectal cancer will be the most common cancer for females≥65 years of age.
Fig. 2 shows the age-specific incidence rates of selected cancers for men and women in 2011. The projection indicates that the incidence of gastric, lung, liver, and colorectal cancers increases gradually with age. In women, the age-specific incidence rates of breast and thyroid cancer will increase with age until the 5th and 6th decades of life, then level off.
2. Mortality
It is estimated that 71,036 cancer deaths will occur during 2011 (Table 1). The CRs of all sites combined in 2011 are projected to become 176.2 and 104.9 per 100,000 for men and women, respectively, and the ASRs of all sites combined are expected to be 136.6 and 58.3 per 100,000 for men and women, respectively (Table 4).
In men, the five leading primary cancer sites for mortality in 2011 are predicted to be lung (CR, 45.7; ASR, 41.2), liver (CR, 32.6; ASR, 29.9), stomach (CR, 23.1; ASR, 17.3), colon and rectum (CR, 17.3; ASR, 13.3), and pancreas (CR, 9.2; ASR, 7.3). In women, lung cancer (CR, 16.6; ASR, 9.4) is projected to be the leading cancer site for mortality in 2011, followed by cancers of the colon and rectum (CR, 13.4; ASR, 7.4), stomach (CR, 12.3; ASR, 9.7), liver (CR, 10.9; ASR, 7.5), and gallbladder (CR, 7.8; ASR, 4.4).
Fig. 3 shows the age-specific mortality rates of the selected cancers for men and women in 2011. When examined by age, liver cancer is expected to have the highest mortality rates in Korean men up to 60 years of age, followed by lung cancer. In contrast, breast cancer is expected to have the highest mortality rates in Korean women up to 55 years of age, followed by lung cancer.
This report provides the estimated nationwide cancer incidence and mortality in Korea in the current year. There are 216,809 cancer cases and 71,036 cancer deaths expected during 2011 in Korea. In Korean men, gastric, colorectal, lung, liver, and prostate cancers are estimated to be the most common incident cancers, and lung, liver, gastric, colorectal, and pancreatic cancers are estimated to be the most common cancer-related deaths. In Korean women, thyroid, breast, gastric, colorectal, and lung cancer are estimated to be the most common incident cancers and lung, colorectal, stomach, liver, and gallbladder cancers are the most common cancer-related deaths.
Cancer has become an important public health concern in Korea, and as Korea becomes an aged society, the cancer burden will continue to increase. The estimated cancer statistics of the current year in this report can be used as an important source to plan and evaluate the cancer control programs in Korea. The estimates in this report, however, are projected numbers based on statistical models which may vary from year-to-year, hence these estimates should be used with caution.
Acknowledgements
This work was supported by a research grant from the National Cancer Center (No. 1010160), and a National Health Promotion Program grant (No. 1060300) from the Ministry for Health, Welfare and Family Affairs, Republic of Korea.

Conflict of interest relevant to this article was not reported.

  • 1. National Statistical Office [Internet]. 2011. cited 2011 Jan 14Daejeon: National Statistical Office; Available from: http://kostat.go.kr
  • 2. Ministry for Heath, Welfare and Family Affairs2008 Annual report of cancer statistics in Korea. 2010. Seoul: Ministry for Heath, Welfare and Family Affairs.
  • 3. Won YJ, Sung J, Jung KW, Kong HJ, Park S, Shin HR, et al. Nationwide cancer incidence in Korea, 2003-2005. Cancer Res Treat. 2009;41:122–131. PMID: 19809561ArticlePubMedPMCPDF
  • 4. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999~2001: first result using the national cancer incidence database. Cancer Res Treat. 2005;37:325–331. PMID: 19956367ArticlePubMedPMCPDF
  • 5. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin D, et al. International classification of diseases for oncology. 2000. 3rd ed. Geneva: World Health Organization.
  • 6. World Health OrganizationManual of the international statistical classification of diseases, injuries, and causes of death. 1992. 10th rev. Geneva: World Health Organization.
  • 7. Boyle P, Parkin DM. . In: Jensen OM, Parkin DM, MacLennnan R, Muir CS, Skeet RG, editors. Cancer registration: principles and methods. IARC Scientific Publication No. 95. Statistical methods for registries. 1991. Lyon: IARC; p. 126–158.
  • 8. Joinpoint Regression Program, version 3.3 [Internet]. National Cancer Institute. 2011. cited 2011 Jan 6Bethesda: National Cancer Institute; Available from: http://srab.cancer.gov/joinpoint/
  • 9. Segi M. Cancer Mortality for selected sites in 24 countries (1950-1957). 1960. Sendai: Tohoku University School of Medicine.
Fig. 1
Ten leading cancer types for the estimated new cancer cases and deaths by sex in 2011. (A) Estimated new cases. (B) Estimated deaths.
crt-43-12-g001.jpg
Fig. 2
Age-specific cancer incidence rates of major cancers during 2011 in Korea. (A) Male. (B) Female.
crt-43-12-g002.jpg
Fig. 3
Age-specific cancer mortality rates of major cancers during 2011 in Korea. (A) Male. (B) Female.
crt-43-12-g003.jpg
Table 1
Estimated new cancer cases and deaths by sex during 2011 in Korea
Sites Estimated new cases Estimated deaths
Both sexes Male Female Both sexes Male Female
All sites 216,809 110,823 105,986 71,036 44,589 26,447
Lip, oral cavity, and pharynx 2,712 2,037 675 1,025 758 267
Esophagus 2,255 2,058 197 1,269 1,174 95
Stomach 31,036 21,075 9,961 8,955 5,855 3,100
Colon and rectum 29,766 18,063 11,703 7,765 4,375 3,390
Liver 16,687 12,443 4,244 10,989 8,240 2,749
Gallbladdera) 5,232 2,579 2,653 3,785 1,814 1,971
Pancreas 5,175 2,801 2,374 4,420 2,331 2,089
Larynx 1,040 997 43 258 236 22
Lung 21,902 15,496 6,406 15,769 11,578 4,191
Breast 15,418 62 15,356 2,081 18 2,063
Cervix uteri 3,359 - 3,359 841 - 841
Corpus uteri 1,899 - 1,899 248 - 248
Ovary 2,104 - 2,104 945 - 945
Prostate 9,526 9,526 - 1,462 1,462 -
Testis 202 202 - 20 20 -
Kidney 3,966 2,731 1,235 792 514 278
Bladder 3,915 3,153 762 948 687 261
Brain and CNS 1,809 961 848 1,020 552 468
Thyroid 38,119 5,756 32,363 360 106 254
Hodgkin lymphoma 235 145 90 43 27 16
Non-Hodgkin lymphoma 4,195 2,338 1,857 1,428 842 586
Multiple myeloma 1,138 581 557 773 387 386
Leukemia 2,774 1,555 1,219 1,631 939 692
Other and ill-defined 12,345 6,264 6,081 4,209 2,674 1,535

CNS, central nervous system. a)Includes gallbladder and other/unspecified parts of the biliary tract.

Table 2
Estimated crude and age-standardized cancer incidence rates by sex during 2011 in Korea
Sites Crude incidence rates/100,000 Age-standardized incidence rates/100,000a)
Both sexes Male Female Both sexes Male Female
All sites 429.2 437.9 420.5 297.3 336.5 279.7
Lip, oral cavity, and pharynx 5.4 8.0 2.7 3.8 6.1 1.9
Esophagus 4.5 8.1 0.8 3.0 6.3 0.4
Stomach 61.4 83.3 39.5 41.7 62.9 24.4
Colon and rectum 58.9 71.4 46.4 40.1 54.2 28.4
Liver 33.0 49.2 16.8 22.6 36.6 10.2
Gallbladderb) 10.4 10.2 10.5 6.7 7.9 5.7
Pancreas 10.2 11.1 9.4 6.7 8.5 5.2
Larynx 2.1 3.9 0.2 1.4 3.0 0.1
Lung 43.4 61.2 25.4 28.3 47.3 14.5
Breast 30.5 0.2 60.9 21.3 0.2 42.2
Cervix uteri 6.6 - 13.3 4.6 - 8.9
Corpus uteri 3.8 - 7.5 2.6 - 5.1
Ovary 4.2 - 8.3 3.0 - 5.9
Prostate 18.9 37.6 - 12.6 29.5 -
Testis 0.4 0.8 - 0.4 0.8 -
Kidney 7.9 10.8 4.9 5.6 8.1 3.3
Bladder 7.8 12.5 3.0 5.1 9.6 1.6
Brain and CNS 3.6 3.8 3.4 3.1 3.4 2.8
Thyroid 75.5 22.7 128.4 54.3 16.5 92.5
Hodgkin lymphoma 0.5 0.6 0.4 0.4 0.5 0.3
Non-Hodgkin lymphoma 8.3 9.2 7.4 6.1 7.4 5.1
Multiple myeloma 2.3 2.3 2.2 1.5 1.8 1.4
Leukemia 5.5 6.1 4.8 5.1 5.9 4.4
Other and ill-defined 24.4 24.7 24.1 17.5 20.1 15.4

CNS, central nervous system.a)Age adjusted to the World Health Organization (WHO) world standard population, b)Includes gallbladder and other/unspecified parts of biliary tract.

Table 3
Estimated cancer incidence by age group and sex during 2011 in Korea
Rank Age group (yr)
0-14 15-34 35-64 ≥65
Male
1 Leukemia
(4.7)		 Thyroid
(10.0)		 Stomach
(94.8)		 Lung
(480.5)
2 Brain and CNS
(2.4)		 Leukemia
(3.3)		 Colon and rectum
(80.4)		 Stomach
(449.1)
3 Non-Hodgkin lymphoma
(1.8)		 Non-Hodgkin lymphoma
(2.8)		 Liver
(66.7)		 Colon and rectum
(387.7)
4 Kidney
(0.6)		 Colon and rectum
(2.6)		 Lung
(41.1)		 Prostate
(314.2)
5 Testis/Liver
(0.3)		 Stomach
(2.5)		 Thyroid
(38.8)		 Liver
(210.0)
Female
1 Leukemia
(4.2)		 Thyroid
(57.4)		 Thyroid
(230.0)		 Colon and rectum
(191.4)
2 Brain and CNS
(2.1)		 Breast
(10.7)		 Breast
(113.7)		 Stomach
(152.4)
3 Non-Hodgkin lymphoma
(0.9)		 Cervix uteri
(4.5)		 Colon and rectum
(47.2)		 Lung
(126.8)
4 Ovary
(0.7)		 Stomach
(4.5)		 Stomach
(41.8)		 Thyroid
(81.5)
5 Kidney
(0.6)		 Ovary
(2.8)		 Lung
(19.9)		 Liver
(75.9)

CNS, central nervous system.

Table 4
Estimated crude and age-standardized cancer mortality rates by sex during 2011 in Korea
Sites Crude mortality rates/100,000 Age-standardized mortality rates/100,000a)
Both sexes Male Female Both sexes Male Female
All sites 140.6 176.2 104.9 90.9 136.6 58.3
Lip, oral cavity, and pharynx 2.0 3.0 1.1 1.3 2.2 0.5
Esophagus 2.5 4.6 0.4 1.6 3.6 0.3
Stomach 17.7 23.1 12.3 11.2 17.3 9.7
Colon and rectum 15.4 17.3 13.4 9.8 13.3 7.4
Liver 21.8 32.6 10.9 14.6 29.9 7.5
Gallbladderb) 7.5 7.2 7.8 4.6 6.8 4.4
Pancreas 8.7 9.2 8.3 5.6 7.3 4.2
Larynx 0.5 0.9 0.1 0.3 1.9 0.1
Lung 31.2 45.7 16.6 19.8 41.2 9.4
Breast 4.1 0.1 8.2 2.8 0.1 4.8
Cervix uteri 1.7 - 3.3 1.1 - 2.8
Corpus uteri 0.5 - 1.0 0.3 - 0.4
Ovary 1.9 - 3.7 1.2 - 2.1
Prostate 2.9 5.8 - 1.7 4.5 -
Testis 0.0 0.1 - 0.0 0.0 -
Kidney 1.6 2.0 1.1 1.0 1.8 0.5
Bladder 1.9 2.7 1.0 1.1 2.9 0.5
Brain and CNS 2.0 2.2 0.9 1.5 2.3 1.7
Thyroid 0.7 0.4 1.0 0.4 0.4 0.6
Hodgkin lymphoma 0.1 0.1 0.1 0.1 0.1 0.0
Non-Hodgkin lymphoma 2.7 3.3 2.3 1.9 2.8 1.4
Multiple myeloma 1.5 1.5 1.5 1.0 1.1 0.7
Leukemia 3.2 3.7 2.7 2.4 3.3 1.9
Other and ill-defined 8.3 10.6 6.1 5.4 7.0 4.1

CNS, central nervous system.a)Age adjusted to the World Health Organization (WHO) world standard population, b)Includes gallbladder and other/unspecified parts of biliary tract.

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Clinical correlation between serum pepsinogen level and gastric atrophy in gastric neoplasm
      Jae Hwang Cha, Jin Seok Jang
      The Korean Journal of Internal Medicine.2020; 35(3): 550.     CrossRef
    • Long-term outcomes of liver resection for multiple hepatocellular carcinomas: Single-institution experience with 187 patients
      Soo-Young Lee, Chul-Soo Ahn, Young-In Yoon, Sung-Gyu Lee, Shin Hwang, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park
      Annals of Hepato-Biliary-Pancreatic Surgery.2020; 24(4): 437.     CrossRef
    • Predicted Increases in Incidence of Colorectal Cancer in Developed and Developing Regions, in Association With Ageing Populations
      Kelvin K.F. Tsoi, Hoyee W. Hirai, Felix C.H. Chan, Sian Griffiths, Joseph J.Y. Sung
      Clinical Gastroenterology and Hepatology.2017; 15(6): 892.     CrossRef
    • Single-incision endoscopic thyroidectomy for papillary thyroid cancer: A pilot study
      Jinbeom Cho, Yohan Park, Jongmin Baek, Kiyoung Sung
      International Journal of Surgery.2017; 43: 1.     CrossRef
    • An assessment of quality of life for early phase after adjuvant radiotherapy in breast cancer survivors: a Korean multicenter survey (KROG 14–09)
      Chai Hong Rim, Sung-Ja Ahn, Jin Hee Kim, Won Sup Yoon, Mison Chun, Dae Sik Yang, Jong-Hoon Lee, Kyubo Kim, Moonkyoo Kong, Suzy Kim, Juree Kim, Kyung Ran Park, Young-Joo Shin, Sun Young Ma, Bae-Kwon Jeong, Su Ssan Kim, Yong Bae Kim, Dong Soo Lee, Jaehyung
      Health and Quality of Life Outcomes.2017;[Epub]     CrossRef
    • Development of a mouse model for testing therapeutic agents: the anticancer effect of dienogest on endometrial neoplasms
      Fumitaka Saito, Hironori Tashiro, Munekage Yamaguchi, Ritsuo Honda, Takashi Ohba, Akira Suzuki, Hidetaka Katabuchi
      Gynecological Endocrinology.2016; 32(5): 403.     CrossRef
    • Investigation of Endoscopic and Pathologic Features for Safe Endoscopic Treatment of Superficial Spreading Early Gastric Cancer
      Kyong Joo Lee, Kyung Ho Pak, Woo Jin Hyung, Sung Hoon Noh, Choong Bai Kim, Yong Chan Lee, Hee Man Kim, Sang Kil Lee
      Medicine.2016; 95(14): e3242.     CrossRef
    • Clinical characteristics of primary gastric lymphoma detected during screening for gastric cancer in Korea
      Hyo‐Joon Yang, Changhyun Lee, Seon Hee Lim, Ji Min Choi, Jong In Yang, Su Jin Chung, Seung Ho Choi, Jong Pil Im, Sang Gyun Kim, Joo Sung Kim
      Journal of Gastroenterology and Hepatology.2016; 31(9): 1572.     CrossRef
    • Correlation of Primary Tumor FDG Uptake with Clinicopathologic Prognostic Factors in Invasive Ductal Carcinoma of the Breast
      I. Jo, Seok Kil Zeon, Sung Hoon Kim, Hae Won Kim, Sun Hee Kang, Sun Young Kwon, Su Jin Kim
      Nuclear Medicine and Molecular Imaging.2015; 49(1): 19.     CrossRef
    • Improvement of diabetes and hypertension after gastrectomy: A nationwide cohort study
      Eun Kyung Lee
      World Journal of Gastroenterology.2015; 21(4): 1173.     CrossRef
    • Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm
      Hong Seok Choi, Sun‐Young Lee, Jeong Hwan Kim, In‐Kyung Sung, Hyung Seok Park, Chan Sup Shim, Choon Jo Jin
      Journal of Digestive Diseases.2014; 15(6): 293.     CrossRef
    • Polymorphisms of folate metabolism-related genes and survival of patients with colorectal cancer in the Korean population
      Moon Ju Jang, Jong Woo Kim, Young Joo Jeon, So Young Chong, Sung Pyo Hong, Seong Gyu Hwang, Doyeun Oh, Yun Kyung Cho, Young Geon Ji, Nam Keun Kim
      Gene.2014; 533(2): 558.     CrossRef
    • Impact of body mass index on the prognosis of Korean women with endometrioid adenocarcinoma of the uterus: A cohort study
      Jeong-Yeol Park, Jae-Hyun Cho, Jin-Young Min, Dae-Yeon Kim, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam
      Obstetrics & Gynecology Science.2014; 57(2): 115.     CrossRef
    • Epidemiologic characteristics of cervical cancer in Korean women
      Hyun-Joo Seol, Kyung-Do Ki, Jong-Min Lee
      Journal of Gynecologic Oncology.2014; 25(1): 70.     CrossRef
    • Is Microsatellite Instability Really a Good Prognostic Factor of Colorectal Cancer?
      Ui Sup Shin, Sang Sik Cho, Sun Mi Moon, Sun Hoo Park, Sun Hee Jee, Eun-Joo Jung, Dae-Yong Hwang
      Annals of Coloproctology.2014; 30(1): 28.     CrossRef
    • Wnt3a expression is associated with MMP-9 expression in primary tumor and metastatic site in recurrent or stage IV colorectal cancer
      Myung Ah Lee, Jin-Hee Park, Si Young Rhyu, Seong-Taek Oh, Won-Kyoung Kang, Hee-Na Kim
      BMC Cancer.2014;[Epub]     CrossRef
    • Lesson from 610 liver resections of hepatocellular carcinoma in a single center over 10 years
      Dai Hoon Han, Gi Hong Choi, Jun Yong Park, Sang Hoon Ahn, Kyung Sik Kim, Jin Sub Choi, Kwang-Hyub Han
      World Journal of Surgical Oncology.2014;[Epub]     CrossRef
    • Laparoscopic gastrectomy for gastric cancer: Current evidences
      Georgios D. Lianos, Stefano Rausei, Laura Ruspi, Federica Galli, Alberto Mangano, Dimitrios H. Roukos, Gianlorenzo Dionigi, Luigi Boni
      International Journal of Surgery.2014; 12(12): 1369.     CrossRef
    • Mortality of Urinary Tract Cancer in Inner Mongolia 2008-2012
      Ke-Peng Xin, Mao-Lin Du, Zhi-Jun Li, Yun Li, Wuyuntana Li, Xiong Su, Juan Sun
      Asian Pacific Journal of Cancer Prevention.2014; 15(6): 2831.     CrossRef
    • The Modern Surgical Strategy for Endometrial Cancer: Laparoscopic Surgery
      Joo-Hyun Nam, Jeong-Yeol Park
      Current Obstetrics and Gynecology Reports.2013; 2(1): 19.     CrossRef
    • Comparison of Laparoscopy-Assisted and Totally Laparoscopic Distal Gastrectomy: The Short-Term Outcome at a Low Volume Center
      Byung Seo Choi, Heung-Kwon Oh, Sei Hyeog Park, Jong-Min Park
      Journal of Gastric Cancer.2013; 13(1): 44.     CrossRef
    • Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002)
      Jeong-Yeol Park, Dae-Yeon Kim, Jong-Hyeok Kim, Yong-Man Kim, Kyu-Rae Kim, Young-Tak Kim, Seok Ju Seong, Tae-Jin Kim, Jae Weon Kim, Seok Mo Kim, Duk-Soo Bae, Joo-Hyun Nam
      European Journal of Cancer.2013; 49(4): 868.     CrossRef
    • OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells
      Mi-Jung Kim, Hyun-Jin Nam, Hwang-Phill Kim, Sae-Won Han, Seock-Ah Im, Tae-You Kim, Do-Youn Oh, Yung-Jue Bang
      Cancer Letters.2013; 335(1): 145.     CrossRef
    • Association of the miR‐146aC>G, miR‐149T>C, miR‐196a2T>C, and miR‐499A>G polymorphisms with gastric cancer risk and survival in the korean population
      Dae Ho Ahn, HyungChul Rah, Young‐Kook Choi, Young Joo Jeon, Kyung Tae Min, KyuBum Kwack, Sung Pyo Hong, Seong Gyu Hwang, Nam Keun Kim
      Molecular Carcinogenesis.2013; 52(S1): 39.     CrossRef
    • Effect of sinapic acid against dimethylnitrosamine-induced hepatic fibrosis in rats
      Dong-Su Shin, Kung Wook Kim, Hae Young Chung, Sik Yoon, Jeon-Ok Moon
      Archives of Pharmacal Research.2013; 36(5): 608.     CrossRef
    • Evolution of pancreatoduodenectomy in a tertiary cancer center in India: Improved results from service reconfiguration
      Shailesh V. Shrikhande, Savio George Barreto, B.A. Somashekar, Kunal Suradkar, Guruprasad S. Shetty, Sanjay Talole, Bhawna Sirohi, Mahesh Goel, Parul J. Shukla
      Pancreatology.2013; 13(1): 63.     CrossRef
    • Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin
      Jeong-Yeol Park, Sang-Hun Lee, Seok Ju Seong, Dae-Yeon Kim, Tae-Jin Kim, Jae Weon Kim, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Duk-Soo Bae, Joo-Hyun Nam
      Gynecologic Oncology.2013; 129(1): 7.     CrossRef
    • Is Colonoscopic Screening Necessary for Patients with Gastric Adenoma or Cancer?
      Seung Young Kim, Sung Woo Jung, Jong Jin Hyun, Ja Seol Koo, Rok Seon Choung, Hyung Joon Yim, Sang Woo Lee, Jai Hyun Choi
      Digestive Diseases and Sciences.2013; 58(11): 3263.     CrossRef
    • Pregnancy Outcomes After Fertility-Sparing Management in Young Women With Early Endometrial Cancer
      Jeong-Yeol Park, Seok Ju Seong, Tae-Jin Kim, Jae Weon Kim, Seok Mo Kim, Duk-Soo Bae, Joo-Hyun Nam
      Obstetrics & Gynecology.2013; 121(1): 136.     CrossRef
    • Effect of annual endoscopic screening on clinicopathologic characteristics and treatment modality of gastric cancer in a high‐incidence region of Korea
      Su Jin Chung, Min Jung Park, Seung Joo Kang, Hae Yeon Kang, Goh Eun Chung, Sang Gyun Kim, Hyun Chae Jung
      International Journal of Cancer.2012; 131(10): 2376.     CrossRef
    • Clinical Characteristics and the Expression Profiles of Inflammatory Cytokines/Cytokine Regulatory Factors in Asymptomatic Patients with Nodular Gastritis
      Sung Noh Hong, Seunghyun Jo, Ju Hyun Jang, Jida Choi, Soohyun Kim, Soo Young Ahn, Jeong Hwan Kim, Won Hyeok Choe, Sun-Young Lee, In Kyung Sung, Hyung Seok Park, Chan Sup Shim
      Digestive Diseases and Sciences.2012; 57(6): 1486.     CrossRef
    • RASSF1A and ERCC1 Expression Levels Might Be Predictive of Prognosis in Advanced, Recurrent, and Metastatic Squamous Cell Carcinoma of the Head and Neck Treated with Docetaxel and Cisplatin
      Yong Park, Dae S. Kim, Kyong H. Park, Seung-Kuk Baek, Soon Y. Kwon, Sang W. Shin, Kwang Y. Jung, Chul Y. Kim, Yeol H. Kim, Nam J. Lee, Jun S. Kim, In S. Kim
      Onkologie.2012; 35(11): 673.     CrossRef
    • Oncologic Outcomes of Stage IIIA Colon Cancer for Different Chemotherapeutic Regimens
      Yoo Sung Lee, Hee Cheol Kim, Kyung Ook Jung, Yong Beom Cho, Seong Hyeon Yun, Woo Yong Lee, Ho-Kyung Chun
      Journal of the Korean Society of Coloproctology.2012; 28(5): 259.     CrossRef
    • Mortality and Potential Years of Life Lost of Colorectal cancer between Korea and OECD countries before and after the year 2000
      Dong-Seok Kim, Soo-Won Kang
      Journal of the Korea Academia-Industrial cooperation Society.2012; 13(11): 5261.     CrossRef
    • Emergency department cancer unit and management of oncologic emergencies: experience in Asan Medical Center
      Shin Ahn, Yoon-Seon Lee, Kyung Soo Lim, Jae-Lyun Lee
      Supportive Care in Cancer.2012; 20(9): 2205.     CrossRef
    • Mortality and Potential Years of Life Lost of lung cancer between Korea and OECD countries before and after the year 2000
      Dong-Seok Kim, Ji-Won Park, Soo-Won Kang
      Journal of the Korea Academia-Industrial cooperation Society.2011; 12(7): 3138.     CrossRef
    • Atypical small acinar proliferation of prostate: Follow-up study of 114 patients
      Kyoung Yul Lee, Yoomi Choi, Kyusang Lee, Sumi Yun, Gheeyoung Choe
      Basic and Applied Pathology.2011; 4(4): 116.     CrossRef
    • Gastric Cancer Epidemiology in Korea
      Aesun Shin, Jeongseon Kim, Sohee Park
      Journal of Gastric Cancer.2011; 11(3): 135.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Prediction of Cancer Incidence and Mortality in Korea, 2011
      Cancer Res Treat. 2011;43(1):12-18.   Published online March 31, 2011
      DOI: https://doi.org/10.4143/crt.2011.43.1.12
      Close
    • XML DownloadXML Download
    • 0
    • 1
    • 2
    Prediction of Cancer Incidence and Mortality in Korea, 2011
    Image Image Image
    Fig. 1 Ten leading cancer types for the estimated new cancer cases and deaths by sex in 2011. (A) Estimated new cases. (B) Estimated deaths.
    Fig. 2 Age-specific cancer incidence rates of major cancers during 2011 in Korea. (A) Male. (B) Female.
    Fig. 3 Age-specific cancer mortality rates of major cancers during 2011 in Korea. (A) Male. (B) Female.

    Fig. 1

    Fig. 2

    Fig. 3

    Prediction of Cancer Incidence and Mortality in Korea, 2011
    Sites Estimated new cases Estimated deaths
    Both sexes Male Female Both sexes Male Female
    All sites 216,809 110,823 105,986 71,036 44,589 26,447
    Lip, oral cavity, and pharynx 2,712 2,037 675 1,025 758 267
    Esophagus 2,255 2,058 197 1,269 1,174 95
    Stomach 31,036 21,075 9,961 8,955 5,855 3,100
    Colon and rectum 29,766 18,063 11,703 7,765 4,375 3,390
    Liver 16,687 12,443 4,244 10,989 8,240 2,749
    Gallbladdera) 5,232 2,579 2,653 3,785 1,814 1,971
    Pancreas 5,175 2,801 2,374 4,420 2,331 2,089
    Larynx 1,040 997 43 258 236 22
    Lung 21,902 15,496 6,406 15,769 11,578 4,191
    Breast 15,418 62 15,356 2,081 18 2,063
    Cervix uteri 3,359 - 3,359 841 - 841
    Corpus uteri 1,899 - 1,899 248 - 248
    Ovary 2,104 - 2,104 945 - 945
    Prostate 9,526 9,526 - 1,462 1,462 -
    Testis 202 202 - 20 20 -
    Kidney 3,966 2,731 1,235 792 514 278
    Bladder 3,915 3,153 762 948 687 261
    Brain and CNS 1,809 961 848 1,020 552 468
    Thyroid 38,119 5,756 32,363 360 106 254
    Hodgkin lymphoma 235 145 90 43 27 16
    Non-Hodgkin lymphoma 4,195 2,338 1,857 1,428 842 586
    Multiple myeloma 1,138 581 557 773 387 386
    Leukemia 2,774 1,555 1,219 1,631 939 692
    Other and ill-defined 12,345 6,264 6,081 4,209 2,674 1,535
    Sites Crude incidence rates/100,000 Age-standardized incidence rates/100,000a)
    Both sexes Male Female Both sexes Male Female
    All sites 429.2 437.9 420.5 297.3 336.5 279.7
    Lip, oral cavity, and pharynx 5.4 8.0 2.7 3.8 6.1 1.9
    Esophagus 4.5 8.1 0.8 3.0 6.3 0.4
    Stomach 61.4 83.3 39.5 41.7 62.9 24.4
    Colon and rectum 58.9 71.4 46.4 40.1 54.2 28.4
    Liver 33.0 49.2 16.8 22.6 36.6 10.2
    Gallbladderb) 10.4 10.2 10.5 6.7 7.9 5.7
    Pancreas 10.2 11.1 9.4 6.7 8.5 5.2
    Larynx 2.1 3.9 0.2 1.4 3.0 0.1
    Lung 43.4 61.2 25.4 28.3 47.3 14.5
    Breast 30.5 0.2 60.9 21.3 0.2 42.2
    Cervix uteri 6.6 - 13.3 4.6 - 8.9
    Corpus uteri 3.8 - 7.5 2.6 - 5.1
    Ovary 4.2 - 8.3 3.0 - 5.9
    Prostate 18.9 37.6 - 12.6 29.5 -
    Testis 0.4 0.8 - 0.4 0.8 -
    Kidney 7.9 10.8 4.9 5.6 8.1 3.3
    Bladder 7.8 12.5 3.0 5.1 9.6 1.6
    Brain and CNS 3.6 3.8 3.4 3.1 3.4 2.8
    Thyroid 75.5 22.7 128.4 54.3 16.5 92.5
    Hodgkin lymphoma 0.5 0.6 0.4 0.4 0.5 0.3
    Non-Hodgkin lymphoma 8.3 9.2 7.4 6.1 7.4 5.1
    Multiple myeloma 2.3 2.3 2.2 1.5 1.8 1.4
    Leukemia 5.5 6.1 4.8 5.1 5.9 4.4
    Other and ill-defined 24.4 24.7 24.1 17.5 20.1 15.4
    Rank Age group (yr)
    0-14 15-34 35-64 ≥65
    Male
    1 Leukemia
    (4.7)    		 Thyroid
    (10.0)    		 Stomach
    (94.8)    		 Lung
    (480.5)
    2 Brain and CNS
    (2.4)    		 Leukemia
    (3.3)    		 Colon and rectum
    (80.4)    		 Stomach
    (449.1)
    3 Non-Hodgkin lymphoma
    (1.8)    		 Non-Hodgkin lymphoma
    (2.8)    		 Liver
    (66.7)    		 Colon and rectum
    (387.7)
    4 Kidney
    (0.6)    		 Colon and rectum
    (2.6)    		 Lung
    (41.1)    		 Prostate
    (314.2)
    5 Testis/Liver
    (0.3)    		 Stomach
    (2.5)    		 Thyroid
    (38.8)    		 Liver
    (210.0)
    Female
    1 Leukemia
    (4.2)    		 Thyroid
    (57.4)    		 Thyroid
    (230.0)    		 Colon and rectum
    (191.4)
    2 Brain and CNS
    (2.1)    		 Breast
    (10.7)    		 Breast
    (113.7)    		 Stomach
    (152.4)
    3 Non-Hodgkin lymphoma
    (0.9)    		 Cervix uteri
    (4.5)    		 Colon and rectum
    (47.2)    		 Lung
    (126.8)
    4 Ovary
    (0.7)    		 Stomach
    (4.5)    		 Stomach
    (41.8)    		 Thyroid
    (81.5)
    5 Kidney
    (0.6)    		 Ovary
    (2.8)    		 Lung
    (19.9)    		 Liver
    (75.9)
    Sites Crude mortality rates/100,000 Age-standardized mortality rates/100,000a)
    Both sexes Male Female Both sexes Male Female
    All sites 140.6 176.2 104.9 90.9 136.6 58.3
    Lip, oral cavity, and pharynx 2.0 3.0 1.1 1.3 2.2 0.5
    Esophagus 2.5 4.6 0.4 1.6 3.6 0.3
    Stomach 17.7 23.1 12.3 11.2 17.3 9.7
    Colon and rectum 15.4 17.3 13.4 9.8 13.3 7.4
    Liver 21.8 32.6 10.9 14.6 29.9 7.5
    Gallbladderb) 7.5 7.2 7.8 4.6 6.8 4.4
    Pancreas 8.7 9.2 8.3 5.6 7.3 4.2
    Larynx 0.5 0.9 0.1 0.3 1.9 0.1
    Lung 31.2 45.7 16.6 19.8 41.2 9.4
    Breast 4.1 0.1 8.2 2.8 0.1 4.8
    Cervix uteri 1.7 - 3.3 1.1 - 2.8
    Corpus uteri 0.5 - 1.0 0.3 - 0.4
    Ovary 1.9 - 3.7 1.2 - 2.1
    Prostate 2.9 5.8 - 1.7 4.5 -
    Testis 0.0 0.1 - 0.0 0.0 -
    Kidney 1.6 2.0 1.1 1.0 1.8 0.5
    Bladder 1.9 2.7 1.0 1.1 2.9 0.5
    Brain and CNS 2.0 2.2 0.9 1.5 2.3 1.7
    Thyroid 0.7 0.4 1.0 0.4 0.4 0.6
    Hodgkin lymphoma 0.1 0.1 0.1 0.1 0.1 0.0
    Non-Hodgkin lymphoma 2.7 3.3 2.3 1.9 2.8 1.4
    Multiple myeloma 1.5 1.5 1.5 1.0 1.1 0.7
    Leukemia 3.2 3.7 2.7 2.4 3.3 1.9
    Other and ill-defined 8.3 10.6 6.1 5.4 7.0 4.1
    Table 1 Estimated new cancer cases and deaths by sex during 2011 in Korea

    CNS, central nervous system. a)Includes gallbladder and other/unspecified parts of the biliary tract.

    Table 2 Estimated crude and age-standardized cancer incidence rates by sex during 2011 in Korea

    CNS, central nervous system.a)Age adjusted to the World Health Organization (WHO) world standard population, b)Includes gallbladder and other/unspecified parts of biliary tract.

    Table 3 Estimated cancer incidence by age group and sex during 2011 in Korea

    CNS, central nervous system.

    Table 4 Estimated crude and age-standardized cancer mortality rates by sex during 2011 in Korea

    CNS, central nervous system.a)Age adjusted to the World Health Organization (WHO) world standard population, b)Includes gallbladder and other/unspecified parts of biliary tract.

    Table 1

    Table 2

    Table 3

    Table 4

    Cancer Res Treat : Cancer Research and Treatment
    © Korean Cancer Association.
    Close layer
    TOP